Skip to main content

Table 2 Serum enzymes in bilharzial and non-bilharzial bladder cancerous patients in comparison to healthy persons:

From: Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients

Parameters

Grading progress

Healthy cases

Bilharzial bladder cancerous patients

non-bilharzial bladder cancerous patients

   

I

II

III

I

II

III

  

n = 10

n = 4

n = 5

n = 6

n = 6

n = 4

n = 5

AST (U/L)

Mean ± S.D

28.4 ± 2.3

102.7 ± 6.9

120.6 ± 8.5

132.9 ± 10.1

85.3 ± 4.9

96.5 ± 9.3

107.3 ± 11.6

 

P <

--

H.S

H.S

H.S

H.S

H.S

H.S

ALT (U/L)

Mean ± S.D

26.3 ± 1.8

82.2 ± 3.95

96.5 ± 6.1

111.1 ± 9.9

69.3 ± 6.5

83.3 ± 7.6

99.8 ± 6.7

 

P<

--

H.S

H.S

H.S

H.S

H.S

H.S

LDH (U/L)

Mean ± S.D

139.9 ± 13.8

351.5 ± 20.2

434.7 ± 21.4

489.3 ± 37.6

334.4 ± 15.5

379.1 ± 14.2

408.6 ± 14.2

 

P<

--

H.S

H.S

H.S

H.S

H.S

H.S

Total protein gm%

Mean ± S.D

7.7 ± 0.5

8.30 ± 0.6

8.40 ± 0.4

9.30 ± 0.3

7.40 ± 0.3

7.5 ± 0.4

7.80 + 0.5

 

P <

--

S

S

S

N.S

N.S

N.S

  1. H.S: P < 0.0005 N.S: P < 0.02